Effect of dialysis fluid on blood vessel calcium in kidney patients
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how different types of dialysis fluid affect calcium buildup in the blood vessels of people with kidney disease on hemodialysis. It may help improve heart health for dialysis patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been on hemodialysis for more than 3 months.
- Your vascular access (the site used for dialysis) is working well and you are clinically stable.
- You produce very little urine (250 mL or less per day).
- You are not taking warfarin or similar blood thinners.
- You do not have active cancer, a serious infection, or severe calcium problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called etelcalcetide to see if it can protect vitamin K activity in people with kidney disease and overactive parathyroid glands who are on dialysis. It aims to slow down calcium buildup in blood vessels and reduce heart valve problems.
This trial is for people already enrolled in the OMAGOD pilot study. It tests whether changing the amount of magnesium in a special dialysis fluid can reduce unwanted blood clotting and inflammation during dialysis.
This study compares different patterns of continuous kidney dialysis (called CRRT) to see how they affect calcium levels in the blood when using a citrate-based blood thinner. It may help find the safest way to manage calcium during treatment.
This study tests a special type of dialysis fluid with a higher amount of a mineral buffer (bicarbonate) to see if it helps keep minerals more balanced in your blood. It may improve how your body handles calcium and other minerals during dialysis.
This study tests whether giving amino acids directly into the blood during dialysis can reduce stiffness in blood vessels, which is common in kidney failure and can lead to heart problems. If you are on stable dialysis, this treatment might help improve your vascular health.
This study tests a new way to give a blood thinner during dialysis to people whose bodies cannot break it down normally. It aims to make dialysis safer and more comfortable for people with kidney and liver problems.
Hear when a new Vascular Calcification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.